TUM researchers develop rapid test for severe infections
Researchers have developed a method for assessing the number and structure of aggregated blood platelets (or thrombocytes) that can potentially help quantify the risk of a severe COVID-19 infection. As a result, they have identified a predictive biomarker for the seriousness of a COVID-19 infection. This will allow physicians to adjust treatment at an early stage. The researchers used a method from image-based flow cytometry that permits the rapid analysis of interactions between large numbers of blood cells.When infected with the Sars-CoV-2 virus, the human body produces a series of immune responses. ...
